Literature DB >> 15094769

Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression.

Mark Stoneley1, Anne E Willis.   

Abstract

Initiation of translation in eukaryotic cells can occur by two distinct mechanisms, cap-dependent scanning and internal ribosome entry. The latter mechanism requires the formation of a complex RNA structural element termed an internal ribosome entry segment (IRES). IRESs are located in the 5' untranslated region of the message, and in the presence of trans-acting factors allow the ribosome to be recruited to a site that is a considerable distance from the cap structure. Many cellular mRNAs have now been shown to contain IRESs and it is likely that up to 10% of all mRNAs have the capability to initiate translation by this mechanism. The majority of IRESs that have been identified thus far are found in mRNAs whose protein products are associated with the control of cell growth and cell death, including many growth factors, proto-oncogenes and proteins required for apoptosis. In this review, we discuss the cellular situations when IRESs are required, the trans-acting factors that are necessary for IRES function and deregulation of IRES-mediated translation in tumorigenesis.

Mesh:

Substances:

Year:  2004        PMID: 15094769     DOI: 10.1038/sj.onc.1207551

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  161 in total

1.  Morphine drives internal ribosome entry site-mediated hnRNP K translation in neurons through opioid receptor-dependent signaling.

Authors:  Pin-Tse Lee; Po-Kuan Chao; Li-Chin Ou; Jian-Ying Chuang; Yen-Chang Lin; Shu-Chun Chen; Hsiao-Fu Chang; Ping-Yee Law; Horace H Loh; Yu-Sheng Chao; Tsung-Ping Su; Shiu-Hwa Yeh
Journal:  Nucleic Acids Res       Date:  2014-10-31       Impact factor: 16.971

2.  MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells.

Authors:  Y Shi; P Frost; B Hoang; Y Yang; R Fukunaga; J Gera; A Lichtenstein
Journal:  Oncogene       Date:  2012-02-27       Impact factor: 9.867

3.  Mechanisms of the initiation of protein synthesis: in reading frame binding of ribosomes to mRNA.

Authors:  Tokumasa Nakamoto
Journal:  Mol Biol Rep       Date:  2010-05-14       Impact factor: 2.316

4.  Evidence for translational regulation by the herpes simplex virus virion host shutoff protein.

Authors:  Holly A Saffran; G Sullivan Read; James R Smiley
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

Review 5.  Translation initiation of the HIV-1 mRNA.

Authors:  Théophile Ohlmann; Chloé Mengardi; Marcelo López-Lastra
Journal:  Translation (Austin)       Date:  2014-10-31

6.  IL-6-induced stimulation of c-myc translation in multiple myeloma cells is mediated by myc internal ribosome entry site function and the RNA-binding protein, hnRNP A1.

Authors:  Yijiang Shi; Patrick J Frost; Bao Q Hoang; Angelica Benavides; Sanjai Sharma; Joseph F Gera; Alan K Lichtenstein
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

7.  Role of the highly structured 5'-end region of MDR1 mRNA in P-glycoprotein expression.

Authors:  Rebecca A Randle; Selina Raguz; Christopher F Higgins; Ernesto Yagüe
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

8.  Efficient translation initiation directed by the 900-nucleotide-long and GC-rich 5' untranslated region of the human retrotransposon LINE-1 mRNA is strictly cap dependent rather than internal ribosome entry site mediated.

Authors:  Sergey E Dmitriev; Dmitri E Andreev; Ilya M Terenin; Ivan A Olovnikov; Vladimir S Prassolov; William C Merrick; Ivan N Shatsky
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

9.  Translation initiation factors are not required for Dicistroviridae IRES function in vivo.

Authors:  Nilsa Deniz; Erik M Lenarcic; Dori M Landry; Sunnie R Thompson
Journal:  RNA       Date:  2009-03-19       Impact factor: 4.942

Review 10.  MHC class II regulation by epigenetic agents and microRNAs.

Authors:  Thomas B Tomasi; William J Magner; Jennifer L Wiesen; Julian Z Oshlag; Felicia Cao; Alex N Pontikos; Christopher J Gregorie
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.